Evidence map›Paper›PMID 30133839›Full record

ArticleJournal of veterinary internal medicine2018

Time-dependent antiarrhythmic effects of flecainide on induced atrial fibrillation in horses.

Helena Carstensen, Eva Z Hesselkilde, Merle Fenner, Ameli V Loft-Andersen, Mette Flethøj, Jørgen K Kanters, Stefan M Sattler, Jacob Tfelt-Hansen, Steen Pehrson, Thomas Jespersen and 1 more

Open access · goldAbstract readClinical Trial, Veterinary
In one paragraph

Article in Journal of veterinary internal medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Metformin Protects Against Persistent Atrial Fibrillation in an Equine Model.Circulation. Arrhythmia and electrophysiology · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Effect of selective IBritish journal of pharmacology · 2020
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Helena CarstensenDepartment of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Taastrup, Denmark.
Eva Z HesselkildeDepartment of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Taastrup, Denmark.
Merle FennerDepartment of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Taastrup, Denmark.
Ameli V Loft-AndersenDepartment of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Taastrup, Denmark.
Mette FlethøjDepartment of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Taastrup, Denmark.
Jørgen K KantersDepartment of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, København, Denmark.
Stefan M SattlerDepartment of Cardiology, The Heart Centre, Copenhagen University Hospital, København, Denmark.
Jacob Tfelt-HansenDepartment of Cardiology, The Heart Centre, Copenhagen University Hospital, København, Denmark.
Steen PehrsonDepartment of Cardiology, The Heart Centre, Copenhagen University Hospital, København, Denmark.
Thomas JespersenDepartment of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, København, Denmark.
Rikke BuhlDepartment of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Taastrup, Denmark.ORCID http://orcid.org/0000-0002-8201-0186
University of Copenhagen · DKCopenhagen University Hospital · DK

Funding

European Union Horizon 2020 research and innovation programme Marie Sklodowska-Curie grant agreement No 675351The Augustinus Foundation 14-4713The Kustos Foundation of 1881 14-4713
6 · The paper itself

Abstract

backgroundPharmacological treatment of atrial fibrillation (AF) in horses can be challenging because of low efficacy and adverse effects. Flecainide has been tested with variable efficacy.

objectiveTo test whether the efficacy of flecainide is dependent on AF duration. ANIMALS: Nine Standardbred mares.

methodsFactorial study design. All horses were instrumented with a pacemaker and assigned to a control or an AF group. On day 0, all horses were in sinus rhythm and received 2 mg/kg flecainide IV. Atrial fibrillation subsequently was induced in the AF group by pacemaker stimulation. On days 3, 9, 27, and 55, flecainide was administered to all horses, regardless of heart rhythm.

resultsAll horses in AF cardioverted to sinus rhythm on days 3 and 9. On day 27, 5/6 horses cardioverted, whereas only 2/6 cardioverted on day 55. The time from the start of flecainide infusion to cardioversion (range, 3-185 min, log transformed) showed linear correlation with the cumulative duration of AF (r CONCLUSIONS AND CLINICAL IMPORTANCE: Flecainide is effective for cardioversion of short-term induced AF, but the effect decreases with AF duration. Controlling heart rate may minimize adverse effects caused by flecainide, but the drug should be used with great caution.

Indexed as

AnimalsAnti-Arrhythmia AgentsAtrial FibrillationFemaleFlecainideHorse DiseasesHorsesPacemaker, ArtificialTime FactorsAnti-Arrhythmia AgentsFlecainidearrhythmiaatriacardioversionelectrocardiographyheartwide QRS tachycardia

Identifiers

PMID30133839
PMCPMC6189357
OpenAlexW2888220389

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.